103 related articles for article (PubMed ID: 8960390)
41. Formation of N-alkylprotoporphyrin IX from metabolism of diallyl sulfone in lung and liver.
Black GP; Collins KS; Blacquiere DP; Forkert PG
Drug Metab Dispos; 2006 Jun; 34(6):895-900. PubMed ID: 16510538
[TBL] [Abstract][Full Text] [Related]
42. Metabolism of DHEA by cytochromes P450 in rat and human liver microsomal fractions.
Fitzpatrick JL; Ripp SL; Smith NB; Pierce WM; Prough RA
Arch Biochem Biophys; 2001 May; 389(2):278-87. PubMed ID: 11339818
[TBL] [Abstract][Full Text] [Related]
43. Porphyrinogenic xenobiotic-induced N-alkylprotoporphyrin IX formation: a bioassay utilizing chick embryo hepatic ferrochelatase.
Gamble JT; Nakatsu K; Marks GS
J Pharmacol Toxicol Methods; 2002; 47(1):25-32. PubMed ID: 12387936
[TBL] [Abstract][Full Text] [Related]
44. A specific loss of growth hormone abolished sex-dependent expression of hepatic cytochrome P450 in dwarf rats: reversal of the profiles by growth hormone-treatment.
Shimada M; Murayama N; Nagata K; Hashimoto H; Ishikawa H; Yamazoe Y
Arch Biochem Biophys; 1997 Jan; 337(1):34-42. PubMed ID: 8990265
[TBL] [Abstract][Full Text] [Related]
45. Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation.
Murray M; Butler AM
J Pharmacol Exp Ther; 1996 Dec; 279(3):1447-52. PubMed ID: 8968370
[TBL] [Abstract][Full Text] [Related]
46. Expression and inducibility of cytochrome P450 isoforms in 1-year-old intrasplenic liver cell transplants in rats.
Lupp A; Danz M; Müller D; Klinger W
Transpl Int; 2002 Mar; 15(2-3):96-107. PubMed ID: 11935166
[TBL] [Abstract][Full Text] [Related]
47. Porphyrinogenic activity and ferrochelatase-inhibitory activity of sydnones in chick embryo liver cells.
Sutherland EP; Marks GS; Grab LA; Ortiz de Montellano PR
FEBS Lett; 1986 Mar; 197(1-2):17-20. PubMed ID: 3949013
[TBL] [Abstract][Full Text] [Related]
48. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
Goosen TC; Mills DE; Hollenberg PF
J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
[TBL] [Abstract][Full Text] [Related]
49. [Involvement of cytochrome P4503A in the monohydroxylation of ring A of praziquantel in rat liver microsomes].
Zhang YJ; Quan YZ
Yao Xue Xue Bao; 1997; 32(1):5-10. PubMed ID: 11243219
[TBL] [Abstract][Full Text] [Related]
50. Suppression of rat hepatic cytochrome P450s by protein-calorie malnutrition: complete or partial restoration by cysteine or methionine supplementation.
Cho MK; Kim YG; Lee MG; Kim SG
Arch Biochem Biophys; 1999 Dec; 372(1):150-8. PubMed ID: 10562428
[TBL] [Abstract][Full Text] [Related]
51. Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine.
Teiber JF; Hollenberg PF
Carcinogenesis; 2000 Aug; 21(8):1559-66. PubMed ID: 10910959
[TBL] [Abstract][Full Text] [Related]
52. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
53. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
Cherala G; Shapiro BH; D'mello AP
Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
[TBL] [Abstract][Full Text] [Related]
54. Inactivation of multiple hepatic cytochrome P-450 isozymes in rats by allylisopropylacetamide: mechanistic implications.
Bornheim LM; Underwood MC; Caldera P; Rettie AE; Trager WF; Wrighton SA; Correia MA
Mol Pharmacol; 1987 Aug; 32(1):299-308. PubMed ID: 3302670
[TBL] [Abstract][Full Text] [Related]
55. The effects of inhibitors and substrates of different types of cytochrome P450 isozymes on serum dimethadione/trimethadione ratio in rats in vivo.
Nishimura Y; Kurata N; Kobayashi S; Uchida E; Yasuhara H
Res Commun Mol Pathol Pharmacol; 1995 Feb; 87(2):145-54. PubMed ID: 7749652
[TBL] [Abstract][Full Text] [Related]
56. N-alkylation of the haem moiety of cytochrome P-450 caused by substituted dihydropyridines. Preferential attack of different pyrrole nitrogen atoms after induction of various cytochrome P-450 isoenzymes.
De Matteis F; Gibbs AH; Hollands C
Biochem J; 1983 May; 211(2):455-61. PubMed ID: 6870842
[TBL] [Abstract][Full Text] [Related]
57. Active site topology of human cytochrome P450 2E1.
Mackman R; Guo Z; Guengerich FP; Ortiz de Montellano PR
Chem Res Toxicol; 1996; 9(1):223-6. PubMed ID: 8924594
[TBL] [Abstract][Full Text] [Related]
58. 2,2-Dialkyl-1,2-dihydroquinolines: cytochrome P-450 catalyzed N-alkylporphyrin formation, ferrochelatase inhibition, and induction of 5-aminolevulinic acid synthase activity.
Lukton D; Mackie JE; Lee JS; Marks GS; Ortiz de Montellano PR
Chem Res Toxicol; 1988; 1(4):208-15. PubMed ID: 2979733
[TBL] [Abstract][Full Text] [Related]
59. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase.
McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR
Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522
[TBL] [Abstract][Full Text] [Related]
60. Differential apoprotein loss of rat liver cytochromes P450 after their inactivation by 3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine: a case for distinct proteolytic mechanisms?
Correia MA; Yao K; Wrighton SA; Waxman DJ; Rettie AE
Arch Biochem Biophys; 1992 May; 294(2):493-503. PubMed ID: 1567205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
